Pharmaceutical Manufacturing and their Waste Management Programs
Pharmaceutical manufacturing mainly deals with manufacturing of useful medicines that can fight against common as well as crucial diseases. From the raw materials, pharmaceutical manufacturing plants develop the efficient medicines. . Each of the drug manufacturing step may result in the generation of liquid and solid wastes, hazardous air emissions, good management practices (GMP) is highly mandatory.
Various Environmental Assessment (EA) programs and Good Management Practices (GMP) are practiced in numerous counties and have shown to produce highly efficient results in minimizing the extents of exposure of workers to hazardous drugs and other exhausted harmful substances in the manufacturing plants.
The EA program mainly deals with the parent drug and not its derivatives. The toxic characteristics of several drug by-products can be reduced through this EA program that mainly involves the studies on chemical, physical and biodegradable properties of the harmful drugs. It also includes process like photolysis and performs various tests on aqueous toxicity. Numerous treatment plans and sequences are also followed to treat the hazardous wastes.
Several reports have been published to describe the perilous characteristics of wastes and by-products of drug manufacturing industries. Particulate matters and volatile organic compounds are the basic constituents of the air pollution. As drug manufacturing plants involve numerous procedures for cleaning of the equipments and the robust machineries, several liquid effluents containing noxious residues results out from these cleaning processes. Hence, waste treatment by the pharmaceutical plants is very much necessary to save the mankind from the disastrous effects of the harmful drugs.
About the Author:
For more information on Pharmaceutical engineering and the benefits of Pharmaceutical manufacturing please visit the mentioned website